2m 2m 2m 2m 2m 2m 2m
RAPPORT THERA (RAPP)
NASDAQ
$38.50+$3.60 (+10.31%)
Price as of Jun 03, 2026 5:14 PM EDT- $1.9BMarket Cap
- 185.13%1-Year Change
- BiotechnologyIndustry
RAPPORT THERA (RAPP)
$38.50+$3.60 (+10.31%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FMR LLC | 19.64% | 7.2M | +57,074 (+0.80%) | Mar 31, 2026 |
TRV GP V, LLC | 19.55% | 7.1M | 0 (0.00%) | Mar 31, 2026 |
ARCH VENTURE MANAGEMENT, LLC | 10.22% | 3.7M | 0 (0.00%) | Mar 31, 2026 |
CAPITAL INTERNATIONAL INVESTORS | 8.49% | 3.1M | -304,556 (-9.83%) | Mar 31, 2026 |
CORMORANT ASSET MANAGEMENT, LP | 8.10% | 3.0M | -70,000 (-2.37%) | Mar 31, 2026 |
GOLDMAN SACHS GROUP INC | 8.06% | 2.9M | -59,628 (-2.03%) | Mar 31, 2026 |
BLACKROCK, INC. | 6.87% | 2.5M | +74,093 (+2.96%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
SMALLCAP WORLD FUND INC | 9.96% | 3.6M | +232,051 (+6.38%) | Mar 31, 2026 |
FIDELITY MT VERNON STREET TRUST | 8.64% | 3.2M | +9,433 (+0.30%) | Feb 28, 2026 |
iSHARES TRUST | 3.79% | 1.4M | +41,340 (+2.99%) | Mar 31, 2026 |
VANGUARD INDEX FUNDS | 3.54% | 1.3M | +9,242 (+0.71%) | Mar 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 2.07% | 756,773 | -18,000 (-2.38%) | Feb 28, 2026 |
T. Rowe Price Health Sciences Fund, Inc. | 1.65% | 601,105 | -42,329 (-7.04%) | Mar 31, 2026 |
T. Rowe Price Small-Cap Value Fund, Inc. | 1.00% | 364,351 | -499 (-0.14%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions265.1M (79.49%)
- Mutual Funds60.3M (18.09%)
- Insiders8.1M (2.42%)
- Other0 (0.00%)
Insider Transactions
- 2.42% (8.1M)Current InsiderOwnership (%, shares)
- 3Number of InsiderBuying (last 12 months)
- $841,885.42Amount of InsiderBuying (last 12 months)
- 5Number of InsiderSelling (last 12 months)
- $1.4BAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Third Rock Ventures V, L.P. | Sell | May 26, 2026 | $743,752.88 | 18,572 | $40.05 | 6.3M |
Third Rock Ventures V, L.P. | Sell | May 11, 2026 | $5.4M | 133,618 | $40.24 | 6.3M |
Third Rock Ventures V, L.P. | Sell | May 08, 2026 | $202,255.51 | 5,018 | $40.31 | 6.4M |
Third Rock Ventures V, L.P. | Sell | May 07, 2026 | $10.9M | 271,495 | $40.12 | 6.4M |
Yeleswaram Krishnaswamy Chief Development Officer | Sell | Apr 08, 2026 | $12,564.00 | 360 | $34.90 | 286,516 |
Gault Cheryl Chief Operating Officer | Sell | Mar 30, 2026 | $200,795.16 | 7,161 | $28.04 | 162,753 |
Gault Cheryl Chief Operating Officer | Sell | Mar 30, 2026 | $81,061.97 | 2,839 | $28.55 | 159,914 |
Yeleswaram Krishnaswamy Chief Development Officer | Sell | Mar 25, 2026 | $303,354.92 | 10,115 | $29.99 | 286,876 |
Gault Cheryl Chief Operating Officer | Sell | Mar 05, 2026 | $58,265.02 | 2,014 | $28.93 | 169,914 |
Bredt David Chief Scientific Officer | Exempt | Feb 19, 2026 | $0.00 | 6,000 | $0.00 | 88,080 |
Bredt David Chief Scientific Officer | Exempt | Feb 19, 2026 | $10,800.00 | 6,000 | $1.80 | 393,075 |
Ceesay Abraham Chief Executive Officer | Sell | Feb 18, 2026 | $103,191.28 | 3,552 | $29.05 | 558,528 |
Ceesay Abraham Chief Executive Officer | Sell | Feb 18, 2026 | $67,969.92 | 2,281 | $29.80 | 556,247 |
Ceesay Abraham Chief Executive Officer | Sell | Feb 18, 2026 | $86,639.15 | 2,983 | $29.04 | 22,829 |
Ceesay Abraham Chief Executive Officer | Sell | Feb 18, 2026 | $62,572.65 | 2,100 | $29.80 | 20,729 |
Bredt David Chief Scientific Officer | Sell | Feb 17, 2026 | $25,218.99 | 900 | $28.02 | 394,675 |
Bredt David Chief Scientific Officer | Sell | Feb 17, 2026 | $156,328.38 | 5,400 | $28.95 | 389,275 |
Bredt David Chief Scientific Officer | Sell | Feb 17, 2026 | $65,107.68 | 2,200 | $29.59 | 387,075 |
Ignelzi Troy A. Chief Financial Officer | Award | Feb 02, 2026 | $0.00 | 148,000 | $0.00 | 148,000 |
Sevigny Jeffrey Chief Medical Officer | Award | Feb 02, 2026 | $0.00 | 130,000 | $0.00 | 130,000 |
Gault Cheryl Chief Operating Officer | Award | Feb 02, 2026 | $0.00 | 132,000 | $0.00 | 132,000 |
Ceesay Abraham Chief Executive Officer | Award | Feb 02, 2026 | $0.00 | 428,000 | $0.00 | 428,000 |
Bredt David Chief Scientific Officer | Award | Feb 02, 2026 | $0.00 | 103,000 | $0.00 | 103,000 |
Ceesay Abraham Chief Executive Officer | Sell | Jan 20, 2026 | $152,333.46 | 5,833 | $26.12 | 562,080 |
Ceesay Abraham Chief Executive Officer | Sell | Jan 20, 2026 | $132,737.46 | 5,083 | $26.11 | 25,812 |
Bredt David Chief Scientific Officer | Sell | Jan 15, 2026 | $222,651.65 | 8,300 | $26.83 | 395,775 |
Bredt David Chief Scientific Officer | Sell | Jan 15, 2026 | $5,480.00 | 200 | $27.40 | 395,575 |
Yeleswaram Krishnaswamy Chief Development Officer | Award | Dec 31, 2025 | $0.00 | 9,000 | $0.00 | 299,831 |
Bredt David Chief Scientific Officer | Award | Dec 31, 2025 | $0.00 | 18,000 | $0.00 | 410,642 |
Yeleswaram Krishnaswamy Chief Development Officer | Sell | Dec 31, 2025 | $85,342.00 | 2,840 | $30.05 | 296,991 |